Skip to main content
logo
Adverum Biotechnologies, Inc. (ADVM)
Dec 9, 2025 - ADVM was delisted (reason: acquired by LLY)
4.360
+0.100 (2.35%)
Inactive · Last trade price on Dec 8, 2025

Adverum Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-169.49-130.93-122.12-154.54-145.54-117.51
Depreciation & Amortization
2.923.655.646.534.654.16
Stock-Based Compensation
11.4414.3517.5720.0825.1920.39
Other Adjustments
15.5819.5516.513.993.810.94
Changes in Accounts Payable
2.95-0.26-0.370.85-1.611.59
Changes in Accrued Expenses
9.293.02-5.40.143.274.15
Changes in Other Operating Activities
1.290.570.481.26-3.256.95
Operating Cash Flow
-130.91-92.46-90.9-108.09-107.83-79.29
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Capital Expenditures
-0.62-0.39-0.81-11.82-15.12-11.84
Purchases of Investments
-54.43-101.9-36.72-104.36-407.51-570.39
Proceeds from Sale of Investments
100.760.4134.4257.9501.35302.06
Investing Cash Flow
45.65-41.8996.88141.7278.71-280.17

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Long-Term Debt Repaid
-----0.24-0.06
Net Long-Term Debt Issued (Repaid)
-----0.24-0.06
Issuance of Common Stock
-1200.490.612.64358.09
Repurchase of Common Stock
------2.04
Net Common Stock Issued (Repurchased)
-1200.490.612.64356.05
Other Financing Activities
---0.42---
Financing Cash Flow
0.481200.070.612.4355.99

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash Flow
-84.9-14.356.0434.24-26.73-3.47
Beginning Cash & Cash Equivalents
-76.9870.9336.763.4266.9
Ending Cash & Cash Equivalents
-84.962.6376.9870.9336.763.42

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Free Cash Flow
-131.53-92.85-91.71-119.91-122.95-91.14
Free Cash Flow Growth
------
FCF Margin
--9285.00%-2547.50%--1639.39%-
Free Cash Flow Per Share
-6.28-4.69-9.10-12.08-12.54-10.70
Levered Free Cash Flow
-153.67-124.33-122.57-157.58-157.84-112.57
Unlevered Free Cash Flow
-159.31-132.57-129.39-160.18-158.19-114.08
SEC Filings: 10-K · 10-Q